Pirbright continues to grow international collaborations to fight and prevent infectious disease
On 30 March 2022 Pirbright signed a memorandum of understanding (MOU) with the University of Saskatchewan’s Vaccine and Infectious Disease Organization (VIDO) in Canada.
This exciting collaboration highlights the Institute’s global commitment to prevent and control infectious disease.
The agreement will encourage knowledge exchange between experts from the two institutes, which will increase the capacity for vaccine innovation and pandemic preparedness throughout the world.